Cargando…

Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer

IMPORTANCE: The American Institute for Cancer Research and American Cancer Society regularly publish modifiable lifestyle recommendations for cancer prevention. Whether these recommendations have an impact on high-risk breast cancer survival remains unknown. OBJECTIVE: To investigate whether adheren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cannioto, Rikki A., Attwood, Kristopher M., Davis, Evan W., Mendicino, Lucas A., Hutson, Alan, Zirpoli, Gary R., Tang, Li, Nair, Nisha M., Barlow, William, Hershman, Dawn L., Unger, Joseph M., Moore, Halle C. F., Isaacs, Claudine, Hobday, Timothy J., Hortobagyi, Gabriel N., Gralow, Julie R., Albain, Kathy S., Budd, G. Thomas, Ambrosone, Christine B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160875/ https://www.ncbi.nlm.nih.gov/pubmed/37140922 http://dx.doi.org/10.1001/jamanetworkopen.2023.11673

Ejemplares similares

Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
por: Mongiovi, Jennifer M., et al.
Publicado: (2018)

Supplement use during an intergroup clinical trial for breast cancer (S0221)
por: Zirpoli, Gary R., et al.
Publicado: (2013)

Germline genetic variants in ABCB1, ABCC1, and ALDH1A1 and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer
por: Yao, Song, et al.
Publicado: (2013)

How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?
por: Crew, Katherine D., et al.
Publicado: (2017)

Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221
por: Chen, Ciao-Sin, et al.
Publicado: (2023)

“Move more, sit less” is a feasible and impactful guideline for improving cancer survival
por: Cannioto, Rikki A
Publicado: (2023)

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials
por: Unger, Joseph M., et al.
Publicado: (2022)

Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)
por: Bergqvist, Mattias, et al.
Publicado: (2023)

Application of the skew exponential power distribution to ROC curves
por: Attwood, Kristopher, et al.
Publicado: (2022)

47982 Reversing the resistance to chemotherapy in White and Black patients with triple negative breast cancer (TNBC).
por: Gandhi, Shipra, et al.
Publicado: (2021)

Practical and robust test for comparing binomial proportions in the randomized phase II setting
por: Attwood, Kristopher, et al.
Publicado: (2021)

Leveraging Homologous Hypotheses for Increased Efficiency in Tumor Growth Curve Testing
por: Hutson, Alan D., et al.
Publicado: (2023)

Leveraging homologous hypotheses for increased efficiency in tumor growth curve testing
por: Hutson, Alan D., et al.
Publicado: (2023)

Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials
por: Unger, Joseph M., et al.
Publicado: (2020)

Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings
por: Unger, Joseph M., et al.
Publicado: (2020)

Trends in Obesity Prevalence Among Patients Enrolled in Clinical Trials for Obesity-Related Cancers, 1986 to 2016
por: Vaidya, Riha, et al.
Publicado: (2022)

Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630
por: Potkul, Ronald K, et al.
Publicado: (2016)

Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation
por: Unger, Joseph M, et al.
Publicado: (2019)

Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 Pandemic
por: Unger, Joseph M., et al.
Publicado: (2021)

A comparison of nurses’ and physicians’ perception of cancer treatment burden based on reported adverse events
por: Lee, Shing M., et al.
Publicado: (2019)

Racial differences in CD8(+) T cell infiltration in breast tumors from Black and White women
por: Abdou, Yara, et al.
Publicado: (2020)

Investigator Use of Social Media for Recruitment of Patients for Cancer Clinical Trials
por: Sedrak, Mina S., et al.
Publicado: (2020)

Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials
por: Unger, Joseph M., et al.
Publicado: (2018)

Association of National Cancer Institute–Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications
por: Unger, Joseph M., et al.
Publicado: (2019)

Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies
por: Unger, Joseph M, et al.
Publicado: (2020)

Trends in Cruciferous Vegetable Consumption and Associations with Breast Cancer Risk: A Case-Control Study
por: Lin, Tengda, et al.
Publicado: (2017)

“When Offered to Participate”: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials
por: Unger, Joseph M, et al.
Publicado: (2020)

A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102
por: Gralow, Julie R., et al.
Publicado: (2013)

Persistent Disparity: Socioeconomic Deprivation and Cancer Outcomes in Patients Treated in Clinical Trials
por: Unger, Joseph M., et al.
Publicado: (2021)

Comment on “Chemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systemic Review and Individual Patient Data Meta-Analysis”
por: Stiles, Zachary E., et al.
Publicado: (2023)

Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204
por: Hwang, Jessica P., et al.
Publicado: (2022)

Association Between Recreational Physical Activity and mTOR Signaling Pathway Protein Expression in Breast Tumor Tissue
por: Cheng, Ting-Yuan David, et al.
Publicado: (2023)

NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
por: Ademuyiwa, Foluso O., et al.
Publicado: (2012)

Body fatness and breast cancer risk in women of African ancestry
por: Bandera, Elisa V, et al.
Publicado: (2013)

Correction: NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
por: Ademuyiwa, Foluso O., et al.
Publicado: (2012)

Clinical relevance of the 21-gene Recurrence Score(®) assay in treatment decisions for patients with node-positive breast cancer in the genomic era
por: Mamounas, Eleftherios P., et al.
Publicado: (2018)

Genetic Variants in COX2 and ALOX Genes and Breast Cancer Risk in White and Black Women
por: Mongiovi, Jennifer M., et al.
Publicado: (2021)

Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation
por: Vaidya, Riha, et al.
Publicado: (2023)

Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study
por: Greenlee, Heather, et al.
Publicado: (2014)

Does alcohol increase breast cancer risk in African-American women? Findings from a case–control study
por: Chandran, U, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t3hg05s6b2nml16v7np0mb7esd